This booklet explains the relationship between MDR-TB, DOTS, and DOTS-Plus and how projects can become a DOTS-Plus pilot project that can benefit from concessionary prices negotiated for second-line anti-TB drugs by the Working Group.
Format:
Booklet
Publication Date:
2000
ID:
32225
- Managers and Supervisors
- TB
- MDR TB
- Treatment- Directly Observed Therapy (DOT)